Plexus (PLXS) Financials

$130.72 -1.01 (-0.77%)

Closing price 05/30/2025 04:00 PM Eastern

Extended Trading

$131.20 +0.47 (+0.36%)

As of 05/30/2025 04:44 PM Eastern

Annual Income Statements for Plexus

This table shows Plexus' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	9/28/2024	9/30/2023	10/1/2022	10/2/2021	10/3/2020	9/28/2019	9/29/2018	9/30/2017	10/1/2016	10/3/2015
Net Income / (Loss) Attributable to Common Shareholders	147	151	138	141	117	109	13	112	76	94
Consolidated Net Income / (Loss)	112	139	138	139	117	109	13	112	76	94
Net Income / (Loss) Continuing Operations	112	139	138	139	117	109	13	112	76	94
Total Pre-Tax Income	130	161	158	160	135	126	108	122	87	106
Total Operating Income	168	196	178	176	153	142	118	130	99	115
Total Gross Profit	379	395	347	323	313	292	258	256	227	240
Total Revenue	3,961	4,210	3,811	3,369	3,390	3,164	2,874	2,528	2,556	2,654
Operating Revenue	3,961	4,210	3,811	3,369	3,390	3,164	2,874	2,528	2,556	2,654
Total Cost of Revenue	3,582	3,816	3,464	3,046	3,078	2,873	2,616	2,272	2,329	2,415
Operating Cost of Revenue	3,582	3,816	3,464	3,046	3,078	2,873	2,616	2,272	2,329	2,415
Total Operating Expenses	211	199	169	147	159	150	139	126	128	124
Selling, General & Admin Expense	191	176	167	144	153	148	139	126	121	122
Restructuring Charge	20	23	2.02	3.27	6.00	1.68	0.00	0.00	7.03	1.70
Total Other Income / (Expense), net	-38	-35	-20	-16	-18	-16	-11	-8.09	-12	-9.14
Interest Expense	29	32	16	14	16	13	12	14	15	14
Interest & Investment Income	3.86	3.14	1.31	1.37	1.88	1.95	4.70	5.04	4.24	3.50
Other Income / (Expense), net	-13	-6.40	-5.33	-2.98	-3.69	-5.20	-3.14	0.45	-1.65	1.32
Income Tax Expense	18	22	20	21	18	17	95	9.76	11	12
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	-54	-22	-	-5.32	-	-	-	-	-	-
Basic Earnings per Share	$4.08	$5.04	$4.96	$4.86	$4.02	$3.59	$0.40	$3.33	$2.29	$2.81
Weighted Average Basic Shares Outstanding	27.40M	27.58M	27.86M	28.58M	29.20M	30.27M	33.00M	33.61M	33.37M	33.62M
Diluted Earnings per Share	$4.01	$4.95	$4.86	$4.76	$3.93	$3.50	$0.38	$3.24	$2.24	$2.74
Weighted Average Diluted Shares Outstanding	27.91M	28.11M	28.44M	29.17M	29.92M	31.07M	33.92M	34.55M	34.10M	34.38M
Weighted Average Basic & Diluted Shares Outstanding	27.09M	27.47M	27.63M	28.00M	29.20M	29.18M	32.60M	33.70M	33.40M	33.60M

This table shows Plexus' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022
Period end date	3/29/2025	12/28/2024	9/28/2024	6/29/2024	3/30/2024	12/30/2023	9/30/2023	7/1/2023	4/1/2023	12/31/2022	10/1/2022
Net Income / (Loss) Attributable to Common Shareholders	49	37	83	18	16	29	46	16	47	42	50
Consolidated Net Income / (Loss)	39	37	41	25	16	29	40	16	41	42	50
Net Income / (Loss) Continuing Operations	39	37	41	25	16	29	40	16	41	42	50
Total Pre-Tax Income	45	43	45	30	19	35	46	17	48	49	57
Total Operating Income	49	47	54	39	29	45	53	28	57	57	62
Total Gross Profit	98	101	108	94	88	88	97	94	103	101	107
Total Revenue	980	976	1,051	961	967	983	1,024	1,022	1,071	1,094	1,124
Operating Revenue	980	976	1,051	961	967	983	1,024	1,022	1,071	1,094	1,124
Total Cost of Revenue	882	875	943	866	879	894	927	928	968	993	1,017
Operating Cost of Revenue	882	875	943	866	879	894	927	928	968	993	1,017
Total Operating Expenses	49	54	54	55	59	43	43	65	46	44	45
Selling, General & Admin Expense	49	49	54	46	48	43	43	42	46	44	45
Restructuring Charge	0.00	4.68	-	9.22	11	0.00	-	23	0.00	-	-
Total Other Income / (Expense), net	-3.77	-3.37	-8.44	-8.94	-11	-10	-6.94	-11	-9.14	-7.90	-5.37
Interest Expense	3.14	3.55	5.58	7.39	8.29	7.62	8.13	8.23	8.29	6.89	5.54
Interest & Investment Income	0.87	1.23	1.22	1.02	0.82	0.81	0.85	0.60	0.76	0.93	0.45
Other Income / (Expense), net	-1.50	-1.05	-4.09	-2.57	-3.03	-3.50	0.35	-3.19	-1.61	-1.94	-0.28
Income Tax Expense	5.95	6.23	4.19	5.16	2.73	5.63	6.14	1.58	6.96	7.25	6.49
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	-19	-	-	8.67	-	-	-	-	-9.23	-	-
Basic Earnings per Share	$1.44	$1.38	$1.51	$0.92	$0.59	$1.06	$1.46	$0.57	$1.48	$1.53	$1.81
Weighted Average Basic Shares Outstanding	27.11M	27.09M	27.40M	27.36M	27.54M	27.49M	27.58M	27.56M	27.66M	27.64M	27.86M
Diluted Earnings per Share	$1.41	$1.34	$1.48	$0.91	$0.58	$1.04	$1.45	$0.56	$1.45	$1.49	$1.76
Weighted Average Diluted Shares Outstanding	27.66M	27.76M	27.91M	27.77M	27.93M	28.01M	28.11M	27.99M	28.18M	28.31M	28.44M
Weighted Average Basic & Diluted Shares Outstanding	27.09M	27.04M	27.09M	27.23M	27.39M	27.61M	27.47M	-	27.65M	27.70M	27.63M

This table details how cash moves in and out of Plexus' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	9/28/2024	9/30/2023	10/1/2022	10/2/2021	10/3/2020	9/28/2019	9/29/2018	9/30/2017	10/1/2016	10/3/2015
Net Change in Cash & Equivalents	91	-19	4.96	-117	162	-71	-273	135	80	16
Net Cash From Operating Activities	437	166	-26	143	210	115	67	172	128	77
Net Cash From Continuing Operating Activities	437	166	-26	143	210	115	67	172	128	77
Net Income / (Loss) Continuing Operations	112	139	138	139	117	109	13	112	76	94
Consolidated Net Income / (Loss)	112	139	138	139	117	109	13	112	76	94
Depreciation Expense	78	70	63	61	57	52	48	45	47	48
Non-Cash Adjustments To Reconcile Net Income	51	-4.22	481	113	8.61	57	1.07	18	21	13
Changes in Operating Assets and Liabilities, net	196	-39	-708	-170	28	-102	4.42	-3.22	-17	-80
Net Cash From Investing Activities	-95	-93	-102	-57	-50	-89	-75	-38	-27	-35
Net Cash From Continuing Investing Activities	-95	-93	-102	-57	-50	-89	-75	-38	-27	-35
Purchase of Property, Plant & Equipment	-95	-104	-102	-57	-50	-91	-63	-39	-31	-35
Other Investing Activities, net	0.24	11	0.05	0.13	0.24	1.24	0.00	0.00	-	-
Net Cash From Financing Activities	-256	-93	139	-204	-1.46	-97	-265	1.31	-21	-26
Net Cash From Continuing Financing Activities	-256	-93	139	-204	-1.46	-97	-265	1.31	-21	-26
Repayment of Debt	-739	-788	-558	-466	-639	-994	-971	-303	-630	-488
Repurchase of Common Equity	-56	-41	-50	-108	-41	-182	-137	-34	-30	-30
Issuance of Debt	551	749	758	377	679	1,085	834	331	625	483
Other Financing Activities, net	-11	-12	-11	-6.11	-0.11	-5.42	8.22	7.25	14	8.61
Other Net Changes in Cash	4.84	-	-	-	-	-	-	-	-	-
Cash Interest Paid	30	33	15	14	15	16	12	14	15	13
Cash Income Taxes Paid	46	44	17	40	31	26	19	10	11	11

This table details how cash moves in and out of Plexus' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022
Period end date	3/29/2025	12/28/2024	9/28/2024	6/29/2024	3/30/2024	12/30/2023	9/30/2023	7/1/2023	4/1/2023	12/31/2022	10/1/2022
Net Change in Cash & Equivalents	-7.29	-30	78	4.80	33	-24	3.10	-	22	-28	-2.36
Net Cash From Operating Activities	37	54	220	132	88	-3.03	90	-	106	-49	-0.39
Net Cash From Continuing Operating Activities	37	54	220	132	88	-3.03	90	-	106	-49	-0.39
Net Income / (Loss) Continuing Operations	39	37	41	25	16	29	40	-	41	42	50
Consolidated Net Income / (Loss)	39	37	41	25	16	29	40	-	41	42	50
Depreciation Expense	20	19	20	20	19	19	18	-	17	16	16
Non-Cash Adjustments To Reconcile Net Income	75	-82	24	14	8.35	-36	-41	-	-6.54	1.40	283
Changes in Operating Assets and Liabilities, net	-97	79	136	73	44	-15	72	-	54	-109	-350
Net Cash From Investing Activities	-20	-26	-26	-18	-23	-29	-16	-	-26	-22	-16
Net Cash From Continuing Investing Activities	-20	-26	-26	-18	-23	-29	-16	-	-26	-22	-16
Purchase of Property, Plant & Equipment	-20	-27	-26	-17	-23	-29	-24	-	-26	-23	-17
Other Investing Activities, net	-0.08	0.05	0.11	-0.21	0.27	0.07	8.66	-	0.37	1.50	0.16
Net Cash From Financing Activities	-25	-53	-121	-109	-31	5.76	-70	-	-58	39	17
Net Cash From Continuing Financing Activities	-25	-53	-121	-109	-31	5.76	-70	-	-58	39	17
Repayment of Debt	-89	-76	-200	-213	-202	-124	-242	-	-194	-142	-214
Repurchase of Common Equity	-13	-13	-20	-19	-18	0.00	-3.52	-	-12	-11	-3.48
Issuance of Debt	88	40	99	123	196	133	176	-	157	197	234
Other Financing Activities, net	-11	-3.07	-0.12	-0.01	-7.91	-2.91	-0.17	-	-8.19	-4.09	0.15

This table presents Plexus' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	9/28/2024	9/30/2023	10/1/2022	10/2/2021	10/3/2020	9/28/2019	9/29/2018	9/30/2017	10/1/2016	10/3/2015
Total Assets	3,154	3,321	3,393	2,462	2,290	2,001	1,933	1,976	1,766	1,692
Total Current Assets	2,477	2,672	2,816	1,931	1,779	1,538	1,517	1,617	1,433	1,334
Cash & Equivalents	345	256	275	270	386	224	297	569	433	357
Restricted Cash	2.35	0.42	0.67	0.34	2.09	2.49	0.42	0.39	0.00	-
Accounts Receivable	622	662	738	520	482	488	395	366	417	385
Inventories, net	1,311	1,562	1,603	972	763	701	794	655	564	569
Prepaid Expenses	75	50	62	53	32	32	30	28	19	23
Other Current Assets	121	142	139	115	114	91	0.00	-	-	-
Plant, Property, & Equipment, net	0.00	0.00	0.00	0.00	0.00	384	341	315	291	317
Total Noncurrent Assets	677	649	577	531	511	78	74	44	41	40
Noncurrent Deferred & Refundable Income Taxes	74	63	39	27	21	14	11	5.29	4.83	4.66
Other Noncurrent Operating Assets	603	586	538	504	489	65	63	39	36	36
Total Liabilities & Shareholders' Equity	3,154	3,321	3,393	2,462	2,290	2,001	1,933	1,976	1,766	1,692
Total Liabilities	1,829	2,107	2,297	1,434	1,312	1,135	1,011	950	849	849
Total Current Liabilities	1,643	1,813	2,006	1,129	1,004	866	738	908	650	579
Short-Term Debt	157	240	274	66	147	101	5.53	287	79	3.51
Accounts Payable	606	647	806	635	516	445	506	414	397	401
Accrued Expenses	76	71	58	147	103	106	68	49	48	-
Current Employee Benefit Liabilities	94	94	89	75	77	74	67	49	42	49
Other Current Liabilities	709	760	779	-	-	-	-	-	-	44
Total Noncurrent Liabilities	186	294	291	305	309	270	274	43	199	270
Long-Term Debt	90	191	188	187	-	-	183	26	184	258
Noncurrent Deferred Revenue	17	31	42	48	54	60	56	0.00	-	-
Noncurrent Deferred & Payable Income Tax Liabilities	8.23	4.35	6.33	5.68	6.43	5.31	14	0.00	-	-
Other Noncurrent Operating Liabilities	70	68	55	64	61	18	20	16	15	12
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,325	1,214	1,096	1,028	977	866	921	1,026	917	842
Total Preferred & Common Equity	1,325	1,214	1,096	1,028	977	866	921	1,026	917	842
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,325	1,214	1,096	1,028	977	866	921	1,026	917	842
Common Stock	681	662	653	640	622	598	582	556	531	498
Retained Earnings	1,823	1,711	1,572	1,434	1,295	1,179	1,062	1,049	937	861
Treasury Stock	-1,190	-1,134	-1,093	-1,043	-	-	-	-	-	-510
Accumulated Other Comprehensive Income / (Loss)	11	-24	-36	-2.98	-5.06	-18	-12	-4.98	-12	-6.47

This table presents Plexus' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/29/2025	12/28/2024	6/29/2024	3/30/2024	12/30/2023	7/1/2023	4/1/2023	12/31/2022	7/2/2022
Total Assets	3,086	3,071	3,171	3,277	3,305	3,419	3,382	3,395	3,204
Total Current Assets	2,396	2,387	2,541	2,631	2,650	2,799	2,780	2,814	2,654
Cash & Equivalents	311	317	270	265	232	253	270	248	277
Restricted Cash	0.03	0.69	0.02	0.04	0.43	0.59	0.70	0.03	1.22
Accounts Receivable	609	597	644	646	656	707	661	734	614
Inventories, net	1,280	1,290	1,434	1,519	1,575	1,642	1,650	1,645	1,561
Prepaid Expenses	60	54	77	71	55	64	66	68	74
Other Current Assets	136	128	116	131	132	133	133	119	128
Plant, Property, & Equipment, net	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Noncurrent Assets	689	684	630	646	654	620	602	581	550
Noncurrent Deferred & Refundable Income Taxes	74	74	55	63	63	40	39	39	27
Other Noncurrent Operating Assets	616	610	575	583	592	579	562	542	523
Total Liabilities & Shareholders' Equity	3,086	3,071	3,171	3,277	3,305	3,419	3,382	3,395	3,204
Total Liabilities	1,734	1,752	1,905	2,017	2,038	2,235	2,200	2,245	2,146
Total Current Liabilities	1,566	1,565	1,725	1,737	1,744	1,941	1,918	1,954	1,861
Short-Term Debt	121	122	258	246	251	305	294	329	250
Accounts Payable	680	666	593	627	647	697	729	754	853
Accrued Expenses	69	74	63	74	61	277	286	296	298
Current Deferred Revenue	612	625	-	716	-	-	-	-	-
Current Employee Benefit Liabilities	84	78	75	73	75	80	77	64	68
Total Noncurrent Liabilities	168	187	180	280	294	294	282	291	286
Capital Lease Obligations	89	-	-	192	-	-	-	-	-
Noncurrent Deferred Revenue	0.00	17	17	17	31	31	31	42	42
Noncurrent Deferred & Payable Income Tax Liabilities	7.22	7.23	4.29	4.43	4.41	4.44	4.90	5.62	6.29
Other Noncurrent Operating Liabilities	72	74	68	66	66	70	57	56	52
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,352	1,319	1,266	1,260	1,267	1,184	1,182	1,150	1,058
Total Preferred & Common Equity	1,352	1,319	1,266	1,260	1,267	1,184	1,182	1,150	1,058
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,352	1,319	1,266	1,260	1,267	1,184	1,182	1,150	1,058
Common Stock	681	685	671	664	664	656	652	655	648
Retained Earnings	1,899	1,860	1,782	1,757	1,741	1,671	1,655	1,614	1,522
Treasury Stock	-1,215	-	-1,171	-1,152	-1,134	-	-1,117	-1,105	-
Accumulated Other Comprehensive Income / (Loss)	-14	-24	-16	-8.70	-3.44	-12	-7.74	-14	-21

This table displays calculated financial ratios and metrics derived from Plexus' official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	9/28/2024	9/30/2023	10/1/2022	10/2/2021	10/3/2020	9/28/2019	9/29/2018	9/30/2017	10/1/2016	10/3/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-5.93%	10.47%	13.14%	-0.64%	7.14%	10.12%	13.66%	-1.09%	-3.70%	11.61%
EBITDA Growth	-10.33%	10.03%	0.53%	13.54%	9.15%	15.68%	-6.97%	21.00%	-12.23%	9.65%
EBIT Growth	-18.41%	9.58%	-0.25%	15.77%	9.37%	18.86%	-11.67%	33.31%	-16.25%	13.71%
NOPAT Growth	-14.41%	8.71%	1.94%	14.70%	8.63%	754.65%	-88.01%	37.42%	-15.11%	8.96%
Net Income Growth	-19.61%	0.62%	-0.48%	18.24%	8.16%	732.94%	-88.36%	46.63%	-18.98%	8.16%
EPS Growth	-18.99%	1.85%	2.10%	21.12%	12.29%	821.05%	-88.27%	44.64%	-18.25%	8.73%
Operating Cash Flow Growth	163.24%	731.94%	-118.40%	-32.23%	82.45%	72.52%	-61.08%	34.44%	66.82%	-13.41%
Free Cash Flow Firm Growth	395.15%	154.09%	-274.84%	-51.49%	1,770.10%	126.02%	-129.10%	9.66%	55.22%	376.38%
Invested Capital Growth	-11.82%	8.33%	26.80%	9.38%	-0.31%	14.19%	5.49%	3.14%	-0.08%	6.56%
Revenue Q/Q Growth	0.68%	0.00%	0.00%	-2.04%	3.13%	1.25%	3.66%	0.67%	-0.61%	0.09%
EBITDA Q/Q Growth	-1.15%	0.00%	279.48%	-2.60%	7.13%	0.97%	2.14%	5.23%	-3.63%	-1.45%
EBIT Q/Q Growth	-2.47%	0.00%	0.00%	-3.89%	9.25%	0.69%	2.16%	7.26%	-4.77%	-1.85%
NOPAT Q/Q Growth	1.95%	0.00%	0.00%	-3.82%	0.25%	-24.07%	142.19%	10.18%	-5.24%	-3.17%
Net Income Q/Q Growth	0.87%	0.00%	0.00%	-3.05%	0.75%	-24.85%	142.49%	9.71%	-5.88%	-2.67%
EPS Q/Q Growth	0.75%	0.00%	0.00%	-2.26%	1.55%	-21.35%	140.43%	9.46%	-5.49%	-2.84%
Operating Cash Flow Q/Q Growth	42.55%	0.00%	-77.50%	-42.82%	4.77%	255.94%	-26.79%	35.17%	-11.05%	-11.30%
Free Cash Flow Firm Q/Q Growth	40.59%	130.00%	54.59%	-62.81%	0.81%	108.53%	-511.61%	41.40%	-21.31%	-4.61%
Invested Capital Q/Q Growth	-8.97%	-2.41%	5.51%	5.20%	-5.65%	-5.57%	10.43%	0.66%	3.05%	0.43%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	9.56%	9.37%	9.11%	9.60%	9.22%	9.22%	8.96%	10.12%	8.90%	9.03%
EBITDA Margin	5.87%	6.16%	6.18%	6.96%	6.09%	5.97%	5.69%	6.95%	5.68%	6.23%
Operating Margin	4.23%	4.65%	4.68%	5.23%	4.52%	4.49%	4.12%	5.14%	3.89%	4.35%
EBIT Margin	3.90%	4.50%	4.54%	5.14%	4.41%	4.32%	4.01%	5.16%	3.83%	4.40%
Profit (Net Income) Margin	2.82%	3.30%	3.63%	4.12%	3.47%	3.43%	0.45%	4.43%	2.99%	3.55%
Tax Burden Percent	86.32%	86.39%	87.33%	86.60%	86.77%	86.23%	12.12%	91.99%	87.45%	88.75%
Interest Burden Percent	83.81%	85.00%	91.58%	92.57%	90.46%	92.03%	93.46%	93.45%	89.37%	91.04%
Effective Tax Rate	13.68%	13.61%	12.67%	13.40%	13.23%	13.77%	87.88%	8.01%	12.55%	11.25%
Return on Invested Capital (ROIC)	11.08%	12.67%	13.57%	15.77%	14.37%	14.09%	1.81%	15.76%	11.65%	14.15%
ROIC Less NNEP Spread (ROIC-NNEP)	-77.73%	-4.01%	-6.96%	54.86%	-346.82%	72.74%	2.52%	19.25%	19.57%	23.40%
Return on Net Nonoperating Assets (RNNOA)	-2.27%	-0.63%	-0.55%	-1.92%	-1.63%	-1.93%	-0.47%	-4.23%	-2.96%	-2.53%
Return on Equity (ROE)	8.81%	12.04%	13.02%	13.85%	12.75%	12.16%	1.34%	11.54%	8.69%	11.62%
Cash Return on Invested Capital (CROIC)	23.64%	4.67%	-10.06%	6.82%	14.69%	0.84%	-3.53%	12.67%	11.73%	7.79%
Operating Return on Assets (OROA)	4.77%	5.64%	5.90%	7.29%	6.98%	6.96%	5.89%	6.97%	5.66%	7.07%
Return on Assets (ROA)	3.45%	4.14%	4.72%	5.85%	5.48%	5.52%	0.67%	5.99%	4.42%	5.72%
Return on Common Equity (ROCE)	8.81%	12.04%	13.02%	13.85%	12.75%	12.16%	1.34%	11.54%	8.69%	11.62%
Return on Equity Simple (ROE_SIMPLE)	8.44%	11.45%	12.62%	13.51%	12.02%	12.55%	1.42%	10.92%	8.34%	11.20%
Net Operating Profit after Tax (NOPAT)	145	169	156	153	133	122	14	119	87	102
NOPAT Margin	3.66%	4.02%	4.08%	4.53%	3.93%	3.87%	0.50%	4.73%	3.40%	3.86%
Net Nonoperating Expense Percent (NNEP)	88.81%	16.67%	20.53%	-39.09%	361.19%	-58.65%	-0.71%	-3.49%	-7.93%	-9.25%
Cost of Revenue to Revenue	90.44%	90.63%	90.89%	90.40%	90.78%	90.78%	91.04%	89.88%	91.10%	90.98%
SG&A Expenses to Revenue	4.81%	4.17%	4.38%	4.27%	4.52%	4.68%	4.85%	4.98%	4.73%	4.61%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	5.32%	4.72%	4.44%	4.36%	4.70%	4.73%	4.85%	4.98%	5.00%	4.68%
Earnings before Interest and Taxes (EBIT)	155	189	173	173	150	137	115	130	98	117
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	232	259	236	234	206	189	163	176	145	165
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.87	2.15	2.27	2.58	2.17	2.25	2.15	1.89	1.74	1.55
Price to Tangible Book Value (P/TBV)	2.87	2.15	2.27	2.58	2.17	2.25	2.15	1.89	1.74	1.55
Price to Revenue (P/Rev)	0.96	0.62	0.65	0.79	0.63	0.61	0.69	0.77	0.62	0.49
Price to Earnings (P/E)	25.95	17.34	18.01	18.84	18.07	17.90	152.19	17.29	20.87	13.85
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	3.85%	5.77%	5.55%	5.31%	5.53%	5.59%	0.66%	5.78%	4.79%	7.22%
Enterprise Value to Invested Capital (EV/IC)	3.03	2.01	2.09	2.61	2.24	2.16	2.31	2.18	1.91	1.62
Enterprise Value to Revenue (EV/Rev)	0.94	0.66	0.70	0.78	0.61	0.63	0.65	0.67	0.56	0.46
Enterprise Value to EBITDA (EV/EBITDA)	15.95	10.76	11.36	11.26	10.03	10.61	11.48	9.57	9.81	7.32
Enterprise Value to EBIT (EV/EBIT)	23.99	14.72	15.48	15.23	13.83	14.66	16.29	12.90	14.57	10.37
Enterprise Value to NOPAT (EV/NOPAT)	25.61	16.48	17.20	17.29	15.55	16.37	130.85	14.07	16.38	11.82
Enterprise Value to Operating Cash Flow (EV/OCF)	8.49	16.82	0.00	18.51	9.84	17.40	28.06	9.79	11.15	15.82
Enterprise Value to Free Cash Flow (EV/FCFF)	12.00	44.70	0.00	40.01	15.22	275.83	0.00	17.51	16.26	21.46
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.19	0.36	0.42	0.25	0.34	0.33	0.20	0.31	0.29	0.31
Long-Term Debt to Equity	0.07	0.16	0.17	0.18	0.19	0.22	0.20	0.03	0.20	0.31
Financial Leverage	0.03	0.16	0.08	-0.04	0.00	-0.03	-0.19	-0.22	-0.15	-0.11
Leverage Ratio	2.55	2.91	2.76	2.37	2.33	2.20	2.01	1.93	1.97	2.03
Compound Leverage Factor	2.14	2.47	2.52	2.19	2.11	2.03	1.88	1.80	1.76	1.85
Debt to Total Capital	15.73%	26.20%	29.65%	19.77%	25.51%	24.96%	17.00%	23.38%	22.26%	23.71%
Short-Term Debt to Total Capital	10.01%	14.60%	17.59%	5.17%	11.19%	8.73%	0.50%	21.43%	6.66%	0.32%
Long-Term Debt to Total Capital	5.72%	11.60%	12.06%	14.59%	14.32%	16.23%	16.50%	1.95%	15.60%	23.39%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	84.27%	73.80%	70.35%	80.23%	74.49%	75.04%	83.00%	76.62%	77.74%	76.29%
Debt to EBITDA	1.06	1.66	1.96	1.08	1.62	1.52	1.15	1.78	1.81	1.58
Net Debt to EBITDA	-0.43	0.67	0.79	-0.07	-0.26	0.33	-0.67	-1.46	-1.17	-0.58
Long-Term Debt to EBITDA	0.39	0.74	0.80	0.80	0.91	0.99	1.12	0.15	1.27	1.56
Debt to NOPAT	1.71	2.55	2.97	1.66	2.52	2.35	13.16	2.62	3.02	2.56
Net Debt to NOPAT	-0.69	1.03	1.20	-0.11	-0.40	0.50	-7.61	-2.14	-1.96	-0.93
Long-Term Debt to NOPAT	0.62	1.13	1.21	1.23	1.41	1.53	12.77	0.22	2.12	2.52
Altman Z-Score	3.79	3.23	2.88	3.92	3.87	4.06	4.11	3.89	4.03	3.97
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.51	1.47	1.40	1.71	1.77	1.78	2.06	1.78	2.20	2.30
Quick Ratio	0.59	0.51	0.50	0.70	0.86	0.82	0.94	1.03	1.31	1.28
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	309	62	-115	66	136	7.27	-28	96	88	56
Operating Cash Flow to CapEx	458.60%	159.37%	-25.82%	249.70%	420.00%	127.26%	107.37%	453.91%	481.74%	220.87%
Free Cash Flow to Firm to Interest Expense	10.70	1.98	-7.27	4.63	8.41	0.57	-2.29	7.07	5.99	4.04
Operating Cash Flow to Interest Expense	15.12	5.26	-1.65	10.00	13.02	8.97	5.47	12.65	8.73	5.48
Operating Cash Flow Less CapEx to Interest Expense	11.82	1.96	-8.06	6.00	9.92	1.92	0.38	9.86	6.92	3.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.22	1.25	1.30	1.42	1.58	1.61	1.47	1.35	1.48	1.61
Accounts Receivable Turnover	6.17	6.02	6.06	6.73	6.99	7.17	7.56	6.46	6.38	7.49
Inventory Turnover	2.49	2.41	2.69	3.51	4.20	3.84	3.61	3.73	4.11	4.41
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00	8.72	8.76	8.34	8.40	8.14
Accounts Payable Turnover	5.72	5.26	4.81	5.29	6.40	6.04	5.68	5.60	5.84	6.06
Days Sales Outstanding (DSO)	59.16	60.65	60.21	54.27	52.23	50.93	48.29	56.48	57.23	48.73
Days Inventory Outstanding (DIO)	146.39	151.37	135.66	104.01	86.84	95.00	101.09	97.89	88.83	82.78
Days Payable Outstanding (DPO)	63.83	69.46	75.89	68.99	57.00	60.44	64.21	65.15	62.53	60.24
Cash Conversion Cycle (CCC)	141.71	142.56	119.98	89.29	82.07	85.49	85.17	89.22	83.53	71.27
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,225	1,389	1,282	1,011	924	927	812	770	746	747
Invested Capital Turnover	3.03	3.15	3.32	3.48	3.66	3.64	3.63	3.33	3.42	3.67
Increase / (Decrease) in Invested Capital	-164	107	271	87	-2.91	115	42	23	-0.63	46
Enterprise Value (EV)	3,708	2,788	2,676	2,639	2,069	2,006	1,876	1,682	1,425	1,211
Market Capitalization	3,808	2,614	2,490	2,657	2,123	1,944	1,985	1,938	1,595	1,306
Book Value per Share	$48.66	$44.19	$39.54	$36.40	$33.42	$29.56	$28.58	$30.53	$27.42	$25.04
Tangible Book Value per Share	$48.66	$44.19	$39.54	$36.40	$33.42	$29.56	$28.58	$30.53	$27.42	$25.04
Total Capital	1,572	1,645	1,557	1,282	1,312	1,154	1,110	1,339	1,179	1,104
Total Debt	247	431	462	253	335	288	189	313	263	262
Total Long-Term Debt	90	191	188	187	188	187	183	26	184	258
Net Debt	-100	174	186	-17	-53	62	-109	-256	-170	-95
Capital Expenditures (CapEx)	95	104	102	57	50	91	62	38	27	35
Debt-free, Cash-free Net Working Capital (DFCFNWC)	644	843	808	598	535	547	487	428	428	401
Debt-free Net Working Capital (DFNWC)	991	1,100	1,084	868	922	773	785	997	861	758
Net Working Capital (NWC)	834	860	810	802	776	673	779	710	783	755
Net Nonoperating Expense (NNE)	33	30	17	14	16	14	1.29	7.44	11	8.11
Net Nonoperating Obligations (NNO)	-100	174	186	-17	-53	62	-109	-256	-170	-95
Total Depreciation and Amortization (D&A)	78	70	63	61	57	52	48	45	47	49
Debt-free, Cash-free Net Working Capital to Revenue	16.25%	20.02%	21.21%	17.75%	15.77%	17.29%	16.96%	16.91%	16.76%	15.11%
Debt-free Net Working Capital to Revenue	25.02%	26.12%	28.44%	25.78%	27.21%	24.44%	27.32%	39.43%	33.70%	28.57%
Net Working Capital to Revenue	21.05%	20.42%	21.25%	23.81%	22.88%	21.26%	27.13%	28.08%	30.63%	28.43%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$4.08	$5.04	$4.96	$4.86	$4.02	$3.59	$0.40	$3.33	$2.29	$2.81
Adjusted Weighted Average Basic Shares Outstanding	27.40M	27.58M	27.86M	28.58M	29.20M	30.27M	33.00M	33.61M	33.37M	33.62M
Adjusted Diluted Earnings per Share	$4.01	$4.95	$4.86	$4.76	$3.93	$3.50	$0.38	$3.24	$2.24	$2.74
Adjusted Weighted Average Diluted Shares Outstanding	27.91M	28.11M	28.44M	29.17M	29.92M	31.07M	33.92M	34.55M	34.10M	34.38M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	27.09M	27.47M	27.63M	28.00M	28.82M	29.18M	31.47M	33.59M	33.51M	33.42M
Normalized Net Operating Profit after Tax (NOPAT)	162	189	157	155	138	124	83	119	93	104
Normalized NOPAT Margin	4.10%	4.49%	4.13%	4.62%	4.08%	3.92%	2.88%	4.73%	3.64%	3.92%
Pre Tax Income Margin	3.27%	3.82%	4.15%	4.76%	3.99%	3.98%	3.74%	4.82%	3.42%	4.00%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	5.35	6.01	10.90	12.16	9.26	10.65	9.42	9.60	6.68	8.36
NOPAT to Interest Expense	5.01	5.36	9.81	10.71	8.23	9.53	1.17	8.80	5.94	7.34
EBIT Less CapEx to Interest Expense	2.06	2.71	4.49	8.15	6.16	3.60	4.33	6.81	4.87	5.88
NOPAT Less CapEx to Interest Expense	1.72	2.06	3.40	6.70	5.13	2.48	-3.92	6.01	4.13	4.85
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	49.80%	29.44%	36.45%	78.07%	35.23%	167.66%	1,050.87%	30.46%	39.25%	31.80%

This table displays calculated financial ratios and metrics derived from Plexus' official financial filings.

Metric	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022
Period end date	3/29/2025	12/28/2024	9/28/2024	6/29/2024	3/30/2024	12/30/2023	9/30/2023	7/1/2023	4/1/2023	12/31/2022	10/1/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	1.37%	-0.66%	2.60%	-5.96%	-9.71%	-10.18%	-8.89%	0.00%	20.49%	33.82%	33.28%
EBITDA Growth	45.81%	7.28%	-3.75%	125.56%	-36.78%	-15.19%	-7.46%	-60.17%	45.42%	59.17%	35.40%
EBIT Growth	78.83%	9.98%	-7.28%	46.65%	-52.21%	-24.80%	-13.46%	-46.65%	60.89%	87.47%	46.69%
NOPAT Growth	67.82%	6.05%	5.63%	26.97%	-48.14%	-22.63%	-16.19%	-40.28%	58.19%	83.57%	54.22%
Net Income Growth	140.61%	27.56%	2.38%	59.12%	-60.24%	-30.75%	-20.21%	0.00%	52.01%	80.12%	51.34%
EPS Growth	143.10%	28.85%	2.07%	62.50%	-60.00%	-30.20%	-17.61%	0.00%	52.63%	81.71%	51.72%
Operating Cash Flow Growth	-58.21%	1,870.78%	145.03%	0.00%	-17.13%	93.79%	23,017.60%	0.00%	25.64%	45.16%	-103.54%
Free Cash Flow Firm Growth	1,869.31%	1,554.52%	452.06%	160.47%	93.85%	96.61%	71.96%	13.60%	-36.36%	-335.03%	-324.07%
Invested Capital Growth	-12.69%	-17.98%	-11.82%	-5.46%	2.72%	4.15%	8.33%	17.12%	22.33%	89.36%	26.80%
Revenue Q/Q Growth	0.41%	-7.09%	9.35%	-0.64%	-1.60%	-4.04%	0.23%	-4.60%	-2.11%	-2.66%	14.52%
EBITDA Q/Q Growth	2.43%	-5.98%	22.97%	23.13%	-24.64%	-15.64%	188.17%	-65.49%	1.10%	-7.95%	24.03%
EBIT Q/Q Growth	3.22%	-7.95%	35.70%	38.71%	-36.52%	-22.40%	114.63%	-54.80%	-0.12%	-10.70%	32.31%
NOPAT Q/Q Growth	5.46%	-17.87%	50.15%	29.04%	-33.36%	-18.19%	80.48%	-47.30%	-0.58%	-11.38%	28.60%
Net Income Q/Q Growth	4.85%	-9.59%	63.97%	54.81%	-44.42%	-27.44%	154.83%	-61.32%	-3.19%	-16.38%	34.57%
EPS Q/Q Growth	5.22%	-9.46%	62.64%	56.90%	-44.23%	-28.28%	158.93%	-61.38%	-2.68%	-15.34%	32.33%
Operating Cash Flow Q/Q Growth	-31.59%	-75.63%	67.27%	49.90%	2,998.51%	-103.37%	0.00%	0.00%	317.14%	-12,347.45%	98.15%
Free Cash Flow Firm Q/Q Growth	-26.71%	43.58%	93.18%	970.44%	39.75%	65.25%	66.82%	11.46%	66.81%	-187.65%	-2.22%
Invested Capital Q/Q Growth	3.22%	-1.04%	-8.97%	-6.09%	-3.04%	6.39%	-2.41%	2.03%	-1.69%	10.66%	5.51%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	9.97%	10.32%	10.27%	9.83%	9.11%	8.97%	9.45%	9.17%	9.62%	9.25%	9.53%
EBITDA Margin	6.82%	6.68%	6.60%	5.87%	4.74%	6.19%	7.04%	2.45%	6.77%	6.55%	6.93%
Operating Margin	4.98%	4.80%	5.13%	4.08%	3.05%	4.60%	5.21%	2.76%	5.32%	5.24%	5.54%
EBIT Margin	4.82%	4.69%	4.74%	3.82%	2.73%	4.24%	5.24%	2.45%	5.17%	5.06%	5.52%
Profit (Net Income) Margin	3.99%	3.82%	3.92%	2.62%	1.68%	2.97%	3.93%	1.55%	3.81%	3.86%	4.49%
Tax Burden Percent	86.78%	85.68%	90.77%	82.96%	85.62%	83.84%	86.78%	90.92%	85.44%	85.34%	88.61%
Interest Burden Percent	95.21%	94.94%	91.25%	82.62%	71.73%	83.65%	86.43%	69.48%	86.39%	89.24%	91.79%
Effective Tax Rate	13.22%	14.32%	9.23%	17.04%	14.38%	16.16%	13.23%	9.08%	14.56%	14.66%	11.39%
Return on Invested Capital (ROIC)	12.77%	12.10%	14.10%	9.63%	7.37%	10.91%	14.25%	0.00%	0.00%	0.00%	16.33%
ROIC Less NNEP Spread (ROIC-NNEP)	3.70%	6.53%	-6.54%	4.96%	2.71%	7.30%	10.91%	0.00%	0.00%	0.00%	10.70%
Return on Net Nonoperating Assets (RNNOA)	0.10%	0.26%	-0.19%	0.64%	0.43%	1.45%	1.70%	0.00%	0.00%	0.00%	0.85%
Return on Equity (ROE)	12.88%	12.36%	13.91%	10.28%	7.80%	12.35%	15.95%	0.00%	0.00%	0.00%	17.18%
Cash Return on Invested Capital (CROIC)	25.77%	30.68%	23.64%	15.87%	6.86%	6.86%	4.67%	-15.77%	-20.09%	-61.76%	-10.06%
Operating Return on Assets (OROA)	6.02%	5.82%	5.80%	4.56%	3.28%	5.19%	6.57%	0.00%	0.00%	0.00%	7.19%
Return on Assets (ROA)	4.97%	4.74%	4.80%	3.12%	2.02%	3.64%	4.93%	0.00%	0.00%	0.00%	5.85%
Return on Common Equity (ROCE)	12.88%	12.36%	13.91%	10.28%	7.80%	12.35%	15.95%	0.00%	0.00%	0.00%	17.18%
Return on Equity Simple (ROE_SIMPLE)	10.56%	9.09%	0.00%	8.75%	8.06%	9.96%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	42	40	49	33	25	38	46	26	49	49	55
NOPAT Margin	4.32%	4.11%	4.65%	3.39%	2.61%	3.85%	4.52%	2.51%	4.54%	4.47%	4.91%
Net Nonoperating Expense Percent (NNEP)	9.07%	5.56%	20.64%	4.67%	4.67%	3.61%	3.34%	4.98%	5.01%	-51.02%	5.63%
Return On Investment Capital (ROIC_SIMPLE)	2.71%	2.62%	-	-	-	2.21%	-	-	-	-	-
Cost of Revenue to Revenue	90.03%	89.68%	89.73%	90.17%	90.89%	91.03%	90.55%	90.83%	90.38%	90.75%	90.47%
SG&A Expenses to Revenue	5.00%	5.04%	5.15%	4.78%	4.92%	4.37%	4.24%	4.15%	4.30%	4.01%	3.99%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	5.00%	5.51%	5.15%	5.74%	6.06%	4.37%	4.24%	6.41%	4.30%	4.01%	3.99%
Earnings before Interest and Taxes (EBIT)	47	46	50	37	26	42	54	25	55	55	62
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	67	65	69	56	46	61	72	25	72	72	78
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.61	3.32	2.87	2.26	2.10	2.39	2.15	2.32	2.33	2.53	2.27
Price to Tangible Book Value (P/TBV)	2.61	3.32	2.87	2.26	2.10	2.39	2.15	2.32	2.33	2.53	2.27
Price to Revenue (P/Rev)	0.89	1.11	0.96	0.73	0.66	0.74	0.62	0.00	0.00	0.00	0.65
Price to Earnings (P/E)	18.86	28.30	25.95	26.18	24.72	21.98	17.34	0.00	0.00	0.00	18.01
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	5.30%	3.53%	3.85%	3.82%	4.05%	4.55%	5.77%	0.00%	0.00%	0.00%	5.55%
Enterprise Value to Invested Capital (EV/IC)	2.74	3.53	3.03	2.19	1.97	2.19	2.01	2.10	2.12	2.24	2.09
Enterprise Value to Revenue (EV/Rev)	0.87	1.08	0.94	0.75	0.71	0.79	0.66	0.00	0.00	0.00	0.70
Enterprise Value to EBITDA (EV/EBITDA)	13.32	18.05	15.95	12.52	19.22	13.05	10.76	0.00	45.44	50.12	11.36
Enterprise Value to EBIT (EV/EBIT)	19.12	26.93	23.99	18.58	19.22	18.44	14.72	0.00	0.00	0.00	15.48
Enterprise Value to NOPAT (EV/NOPAT)	20.93	29.08	25.61	20.73	20.93	20.48	16.48	0.00	0.00	0.00	17.20
Enterprise Value to Operating Cash Flow (EV/OCF)	7.77	8.67	8.49	9.61	0.00	15.31	16.82	0.00	83.28	228.17	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	9.93	10.36	12.00	13.40	29.11	32.63	44.70	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.16	0.16	0.19	0.28	0.35	0.35	0.36	0.42	0.41	0.45	0.42
Long-Term Debt to Equity	0.07	0.07	0.07	0.07	0.15	0.15	0.16	0.16	0.16	0.16	0.17
Financial Leverage	0.03	0.04	0.03	0.13	0.16	0.20	0.16	0.18	0.14	-0.01	0.08
Leverage Ratio	2.44	2.47	2.55	2.69	2.73	2.77	2.91	2.95	2.87	2.78	2.76
Compound Leverage Factor	2.32	2.34	2.33	2.22	1.96	2.32	2.51	2.05	2.48	2.48	2.53
Debt to Total Capital	13.43%	13.77%	15.73%	21.60%	25.80%	25.92%	26.20%	29.36%	28.99%	30.98%	29.65%
Short-Term Debt to Total Capital	7.75%	7.97%	10.01%	15.98%	14.49%	14.69%	14.60%	18.18%	17.66%	19.75%	17.59%
Long-Term Debt to Total Capital	5.68%	5.80%	5.72%	5.62%	11.31%	11.24%	11.60%	11.18%	11.33%	11.24%	12.06%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	86.57%	86.23%	84.27%	78.40%	74.20%	74.08%	73.80%	70.64%	71.01%	69.02%	70.35%
Debt to EBITDA	0.81	0.89	1.06	1.48	2.98	1.79	1.66	0.00	7.41	8.13	1.96
Net Debt to EBITDA	-0.39	-0.45	-0.43	0.34	1.18	0.85	0.67	0.00	3.26	4.23	0.79
Long-Term Debt to EBITDA	0.34	0.37	0.39	0.39	1.31	0.77	0.74	0.00	2.90	2.95	0.80
Debt to NOPAT	1.28	1.43	1.71	2.46	3.25	2.80	2.55	0.00	0.00	0.00	2.97
Net Debt to NOPAT	-0.61	-0.73	-0.69	0.56	1.28	1.33	1.03	0.00	0.00	0.00	1.20
Long-Term Debt to NOPAT	0.54	0.60	0.62	0.64	1.42	1.21	1.13	0.00	0.00	0.00	1.21
Altman Z-Score	3.74	4.01	3.68	3.28	3.11	3.24	3.10	1.75	1.80	1.80	2.77
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.53	1.53	1.51	1.47	1.51	1.52	1.47	1.44	1.45	1.44	1.40
Quick Ratio	0.59	0.58	0.59	0.53	0.52	0.51	0.51	0.49	0.49	0.50	0.50
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	224	306	213	110	-13	-21	-60	-182	-206	-621	-216
Operating Cash Flow to CapEx	181.67%	202.19%	836.75%	758.17%	384.06%	-10.57%	370.39%	0.00%	401.23%	-211.37%	-2.36%
Free Cash Flow to Firm to Interest Expense	71.44	86.05	38.19	14.92	-1.53	-2.76	-7.44	-22.15	-24.85	-90.01	-38.91
Operating Cash Flow to Interest Expense	11.70	15.09	39.47	17.81	10.59	-0.40	11.05	0.00	12.79	-7.08	-0.07
Operating Cash Flow Less CapEx to Interest Expense	5.26	7.63	34.75	15.46	7.83	-4.16	8.07	0.00	9.60	-10.43	-3.06
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.25	1.24	1.22	1.19	1.20	1.22	1.25	0.00	0.00	0.00	1.30
Accounts Receivable Turnover	6.32	6.31	6.17	5.83	6.11	5.90	6.02	0.00	0.00	0.00	6.06
Inventory Turnover	2.55	2.49	2.49	2.32	2.29	2.31	2.41	0.00	0.00	0.00	2.69
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Payable Turnover	5.46	5.43	5.72	5.53	5.35	5.31	5.26	0.00	0.00	0.00	4.81
Days Sales Outstanding (DSO)	57.73	57.86	59.16	62.66	59.70	61.89	60.65	0.00	0.00	0.00	60.21
Days Inventory Outstanding (DIO)	143.22	146.75	146.39	157.38	159.36	158.08	151.37	0.00	0.00	0.00	135.66
Days Payable Outstanding (DPO)	66.90	67.27	63.83	65.99	68.23	68.79	69.46	0.00	0.00	0.00	75.89
Cash Conversion Cycle (CCC)	134.05	137.34	141.71	154.05	150.83	151.19	142.56	0.00	0.00	0.00	119.98
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,251	1,212	1,225	1,345	1,433	1,478	1,389	1,423	1,395	1,419	1,282
Invested Capital Turnover	2.96	2.94	3.03	2.84	2.83	2.83	3.15	0.00	0.00	0.00	3.32
Increase / (Decrease) in Invested Capital	-182	-266	-164	-78	38	59	107	208	255	669	271
Enterprise Value (EV)	3,433	4,274	3,708	2,944	2,821	3,240	2,788	2,989	2,962	3,182	2,676
Market Capitalization	3,534	4,381	3,808	2,865	2,648	3,029	2,614	2,750	2,750	2,913	2,490
Book Value per Share	$49.99	$48.69	$48.66	$46.28	$45.74	$46.12	$44.19	$42.84	$42.68	$41.63	$39.54
Tangible Book Value per Share	$49.99	$48.69	$48.66	$46.28	$45.74	$46.12	$44.19	$42.84	$42.68	$41.63	$39.54
Total Capital	1,561	1,530	1,572	1,615	1,698	1,710	1,645	1,677	1,665	1,667	1,557
Total Debt	210	211	247	349	438	443	431	492	483	516	462
Total Long-Term Debt	89	89	90	91	192	192	191	187	189	187	188
Net Debt	-101	-107	-100	79	173	211	174	239	212	268	186
Capital Expenditures (CapEx)	20	27	26	17	23	29	24	0.00	26	23	17
Debt-free, Cash-free Net Working Capital (DFCFNWC)	641	626	644	804	875	925	843	910	886	941	808
Debt-free Net Working Capital (DFNWC)	951	944	991	1,074	1,140	1,158	1,100	1,163	1,156	1,189	1,084
Net Working Capital (NWC)	830	822	834	816	894	907	860	858	862	860	810
Net Nonoperating Expense (NNE)	3.27	2.88	7.66	7.42	8.99	8.64	6.02	9.84	7.81	6.75	4.76
Net Nonoperating Obligations (NNO)	-101	-107	-100	79	173	211	174	239	212	268	186
Total Depreciation and Amortization (D&A)	20	19	20	20	19	19	18	0.00	17	16	16
Debt-free, Cash-free Net Working Capital to Revenue	16.15%	15.83%	16.25%	20.45%	21.90%	22.58%	20.02%	0.00%	0.00%	0.00%	21.21%
Debt-free Net Working Capital to Revenue	23.98%	23.87%	25.02%	27.31%	28.54%	28.25%	26.12%	0.00%	0.00%	0.00%	28.44%
Net Working Capital to Revenue	20.93%	20.79%	21.05%	20.74%	22.38%	22.12%	20.42%	0.00%	0.00%	0.00%	21.25%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.44	$1.38	$1.51	$0.92	$0.59	$1.06	$1.46	$0.57	$1.48	$1.53	$1.81
Adjusted Weighted Average Basic Shares Outstanding	27.11M	27.09M	27.40M	27.36M	27.54M	27.49M	27.58M	27.56M	27.66M	27.64M	27.86M
Adjusted Diluted Earnings per Share	$1.41	$1.34	$1.48	$0.91	$0.58	$1.04	$1.45	$0.56	$1.45	$1.49	$1.76
Adjusted Weighted Average Diluted Shares Outstanding	27.66M	27.76M	27.91M	27.77M	27.93M	28.01M	28.11M	27.99M	28.18M	28.31M	28.44M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	27.09M	27.04M	27.09M	27.23M	27.39M	27.61M	27.47M	27.48M	27.65M	27.70M	27.63M
Normalized Net Operating Profit after Tax (NOPAT)	42	44	49	40	35	38	46	47	49	49	55
Normalized NOPAT Margin	4.32%	4.52%	4.65%	4.18%	3.59%	3.85%	4.52%	4.57%	4.54%	4.47%	4.91%
Pre Tax Income Margin	4.59%	4.46%	4.32%	3.15%	1.96%	3.55%	4.53%	1.70%	4.46%	4.52%	5.07%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	15.07	12.89	8.92	4.96	3.19	5.47	6.60	3.04	6.68	8.04	11.19
NOPAT to Interest Expense	13.50	11.30	8.77	4.41	3.04	4.97	5.69	3.12	5.87	7.10	9.96
EBIT Less CapEx to Interest Expense	8.64	5.43	4.21	2.61	0.43	1.71	3.62	3.04	3.49	4.69	8.20
NOPAT Less CapEx to Interest Expense	7.06	3.83	4.05	2.06	0.29	1.21	2.71	3.12	2.68	3.75	6.97
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	44.49%	57.16%	49.80%	35.78%	0.00%	23.37%	29.44%	0.00%	0.00%	0.00%	36.45%

Frequently Asked Questions About Plexus' Financials

When does Plexus's financial year end?

According to the most recent income statement we have on file, Plexus' fiscal year ends in September. Their fiscal year 2024 ended on September 28, 2024.

How has Plexus' net income changed over the last 9 years?

Plexus' net income appears to be on an upward trend, with a most recent value of $111.82 million in 2024, rising from $94.33 million in 2015. The previous period was $139.09 million in 2023. See Plexus' forecast for analyst expectations on what’s next for the company.

What is Plexus's operating income?

Plexus's total operating income in 2024 was $167.73 million, based on the following breakdown:

Total Gross Profit: $378.53 million
Total Operating Expenses: $210.80 million

How has Plexus revenue changed over the last 9 years?

Over the last 9 years, Plexus' total revenue changed from $2.65 billion in 2015 to $3.96 billion in 2024, a change of 49.2%.

How much debt does Plexus have?

Plexus' total liabilities were at $1.83 billion at the end of 2024, a 13.2% decrease from 2023, and a 115.3% increase since 2015.

How much cash does Plexus have?

In the past 9 years, Plexus' cash and equivalents has ranged from $223.76 million in 2019 to $568.86 million in 2017, and is currently $345.11 million as of their latest financial filing in 2024.

How has Plexus' book value per share changed over the last 9 years?

Over the last 9 years, Plexus' book value per share changed from 25.04 in 2015 to 48.66 in 2024, a change of 94.3%.

Related Companies

This page (NASDAQ:PLXS) was last updated on 6/1/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Plexus (PLXS) Financials

Frequently Asked Questions About Plexus' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Plexus (PLXS) Financials

Annual Income Statements for Plexus

Quarterly Income Statements for Plexus

Annual Cash Flow Statements for Plexus

Quarterly Cash Flow Statements for Plexus

Annual Balance Sheets for Plexus

Quarterly Balance Sheets for Plexus

Annual Metrics And Ratios for Plexus

Quarterly Metrics And Ratios for Plexus

Frequently Asked Questions About Plexus' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools